METASTATIC PANCREATIC ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough pancreatic cancer: trial targets specific genetic flaw
Disease control Recruiting nowThis study is testing whether adding a new drug called setidegrasib to standard chemotherapy helps people with advanced pancreatic cancer that has a specific genetic change (KRAS G12D mutation) live longer. About 614 adults whose cancer has spread and cannot be cured by surgery w…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope in battle against deadly pancreatic cancer
Disease control Recruiting nowThis study is testing which of two chemotherapy combinations works better for people with advanced pancreatic cancer that hasn't been treated before. Researchers will compare NALIRIFOX (a newer combination) against mGAP (a modified version of three existing drugs) in 52 patients.…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for tough cancers: experimental drug enters first human testing
Disease control Recruiting nowThis is the first human study of a new chemotherapy drug called TR-002. It aims to find the safest dose and understand side effects for people with advanced solid tumors, including pancreatic cancer, that have stopped responding to standard treatments. The study will enroll 52 pa…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough pancreatic cancers: can adding a targeted drug help patients live longer?
Disease control Recruiting nowThis study is for people with advanced pancreatic cancer that has stopped responding to their first treatment. It is testing if adding a targeted drug called panitumumab to standard second-line chemotherapy helps patients live longer than chemotherapy alone. The trial is specific…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough pancreatic cancers: Four-Drug attack trial opens
Disease control Recruiting nowThis study is testing a new four-drug combination for people with advanced pancreatic cancer that has spread or come back. It combines a new immunotherapy drug (BMS-986340) with an existing immunotherapy (nivolumab) and two standard chemotherapy drugs. The main goals are to see i…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New timing strategy tested to boost chemo against advanced pancreatic cancer
Disease control Recruiting nowThis study is testing whether changing the timing of two standard chemotherapy drugs (gemcitabine and nab-paclitaxel) can improve treatment for pancreatic cancer that has spread. The goal is to see if this adjusted schedule helps shrink tumors better and is tolerable for patients…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Anne Noonan • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Radio waves join fight against deadly pancreatic cancer
Disease control Recruiting nowThis study is testing whether adding a special radio wave device to standard chemotherapy drugs is safe and can better control advanced pancreatic cancer that has spread. It will involve about 30 adults with this diagnosis. The main goal is to see if this combination can keep the…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Light therapy trial aims to boost immune attack on pancreatic cancer
Disease control Recruiting nowThis study is testing a new combination treatment for pancreatic cancer that cannot be removed by surgery or has spread. The approach uses a light-activated drug injected into the tumor to help the patient's own immune system, boosted by an immunotherapy drug (pembrolizumab), bet…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test 'Smart Package' therapy to target deadly pancreatic cancer
Disease control Recruiting nowThis early-phase trial is testing a new treatment for advanced pancreatic cancer that has spread and carries a specific genetic change (KRAS G12D mutation). The treatment uses tiny natural packages from cells (called exosomes) to deliver a gene-silencing drug directly to the canc…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Virtual support tested to ease burden of advanced pancreatic cancer
Symptom relief Recruiting nowThis study is testing whether telehealth coaching sessions can help improve quality of life for people with metastatic pancreatic cancer and their family caregivers. The program offers support for managing physical symptoms, emotional well-being, and the challenges of caregiving …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC